Clinical Trials on Polypoidal Choroidal Vasculopathy in Japan
Total 14 results
-
Nihon UniversityCompletedPolypoidal Choroidal VasculopathyJapan
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Polypoidal Choroidal VasculopathyJapan, Taiwan, Hong Kong, Singapore, Thailand, Korea, Republic of, Malaysia
-
BayerRegeneron PharmaceuticalsCompletedChoroidal NeovascularizationJapan
-
NovartisCompletedSubfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)Japan
-
Kyorin UniversityCompleted
-
Osaka UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedAge Related Macular Degeneration | Neovascular MaculopathyJapan
-
Kyorin UniversityCompletedMyopic Traction MaculopathyJapan
-
PfizerCompletedMacular DegenerationJapan
-
BayerRegeneron PharmaceuticalsCompletedMyopia, PathologicalJapan, Taiwan, Hong Kong, Korea, Republic of, Singapore
-
Kyorin UniversityCompletedVitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction MaculopathyMyopic Traction Maculopathy | Macular Hole Retinal DetachmentJapan
-
Kyorin UniversityCompletedSurgery | High Myopia | MaculopathyJapan
-
Novartis PharmaceuticalsCompletedPathological MyopiaGermany, India, Japan, Turkey, Austria, Switzerland, Italy, Lithuania, Hungary, France, Slovakia, United Kingdom, Korea, Republic of, Portugal, Hong Kong, Canada, Singapore, Spain, Latvia, Poland
-
Assiut UniversityUnknown
-
Eli Lilly and CompanyActive, not recruitingAicardi Goutieres Syndrome | Nakajo-Nishimura Syndrome | Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome | STING-Associated Vasculopathy With Onset in InfancyJapan